RENBP and diabetic cardiomyopathy: Figure 4B–D shows the visualization results of the GO enrichment. The results of the KEGG analysis (Figure 4E,F) show that the co-DEGs were mainly enriched in some metabolic-related diseases (fat digestion and absorption (p-value = 0.006487), diabetic cardiomyopathy (p-value = 0.02558), fat digestion and absorption (p-value = 0.00648)), and in the conduction of the signaling pathway (chemokine signaling pathway (p-value = 0.006356), AGE-RAGE signaling pathway in diabetic complications (p-value = 0.03038), MAPK signaling pathway (p-value = 0.0328)).